2025 American Heart Association (New Orleans)

LBCT Presentations

Erin Bohula – The Effect of EVolocumab in PatiEntS at High CArdiovascuLar RIsk WithoUt Prior Myocardial Infarction or Stroke-Primary Results of the VESALIUS-CV Study

Nicholas Marston – Olezarsen in Patients with Severe Hypertriglyceridemia-The CORE-TIMI 72a and CORE2-TIMI 72b Trials

Other Presentations

Ajar Kochar – Temporary MCS and Cardiogenic Shock-Characterizing Complications in Modern Practice

Yi-Pin Lai – Polygenic Risk Score for Abdominal Aortic Aneurysm in Patients with Cardiometabolic Disease: Analysis of 40,000 Patients from 3 TIMI Trials

Victorien Monguillon – Efficacy and Safety of Very Low Achieved LDL-Cholesterol in Patients with Prior Ischemic Stroke

Victorien Monguillon – Efficacy of Olpasiran by Apolipoprotein(a) Isoform-Size-Insights from the OCEAN(a)-DOSE Trial

Sarah Morrow – Biomarkers in Cardiac Arrest-An Analysis from the Critical Care Cardiology Trials Network

Jun Park – Polygenic Risk Score Associated with Kidney Disease Progression in Patients with Cardiometabolic Disease

Siddharth Patel – Blood Pressure and Symptomatic Hypotension with Dapagliflozin vs. Placebo in Patients Hospitalized with Heart Failure